Genpact (G)
NYSE:G
Want to see G full AI Analyst Report?
Top Page
Genpact
(NYSE:G)
Select Model
Select Model
Rating:71Outperform
Price Target:
$32.00
▼(-6.38% Downside)
Action:Reiterated
Date:05/09/26
The score is supported by solid financials (improved leverage, strong returns, and healthy profitability) and an attractive valuation (low P/E with a ~2.1% yield), plus constructive FY2026 guidance and ATS momentum. These positives are meaningfully offset by weak technicals, with the stock trading well below key moving averages and bearish momentum despite oversold readings.
Positive Factors
Advanced Technology Solutions (ATS) growth
Sustained ATS growth (24% YoY to $345M and ~27% of revenue) plus a >30% pipeline expansion reflects a structural shift to higher‑value, technology-led offerings. This mix change increases recurring, non‑FTE revenues and supports more durable margin and revenue visibility.
Negative Factors
Slower core business services growth
Core legacy services growing just 1.4% YoY shows the company remains dependent on a slower, labor‑intensive base while transitioning to digital offerings. This gap can cap topline growth until ATS and agentic solutions scale sufficiently to offset legacy stagnation.
Read all positive and negative factors
Positive Factors
Negative Factors
Advanced Technology Solutions (ATS) growth
Sustained ATS growth (24% YoY to $345M and ~27% of revenue) plus a >30% pipeline expansion reflects a structural shift to higher‑value, technology-led offerings. This mix change increases recurring, non‑FTE revenues and supports more durable margin and revenue visibility.
Read all positive factors
Genpact Key Performance Indicators (KPIs)
Any
Number of Clients Greater Than $25m Revenue
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Data provided by:
The Fly
The FlyGenpact (G) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.41B
Dividend Yield1.41%
Average Volume (3M)3.20M
Price to Earnings (P/E)10.7
Beta (1Y)0.69
Revenue Growth6.47%
EPS Growth10.82%
CountryUS
Employees145,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)3.30
Shares Outstanding169,506,520
10 Day Avg. Volume3,657,170
30 Day Avg. Volume3,204,109
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.19
Price to Sales (P/S)1.60
P/FCF Ratio11.07
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit3.50
Enterprise Value/Ebitda7.54
Forecast
1Y Price Target
$41.67Price Target Upside21.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)4.07
Revenue Forecast (FY)$5.44B
Genpact Business Overview & Revenue Model
Company Description
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods,...
How the Company Makes Money
Genpact makes money by providing contracted services to enterprise clients, generating revenue primarily from fees for ongoing operations management (managed services/business process services) and project-based professional services (consulting, ...
Genpact Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presents a largely positive picture: accelerating high-value revenue in Advanced Technology Solutions (ATS) and agentic offerings, strong margin expansion, record backlog/pipeline, and meaningful partner and client wins outweigh measured near-term challenges such as slow growth in legacy core business services, early-stage realization of headcount decoupling, and macro/ execution risks tied to rapid adoption of new technologies.Positive Updates
Record start to fiscal year
Total revenue $1.296B, up 6.7% year-over-year; company reiterates full-year expectation of at least 7% growth (as-reported). Q2 revenue guidance $1.324B–$1.336B (~6% growth at midpoint).
Negative Updates
Slower growth in core business services
Core business services revenue $951M increased only 1.4% year-over-year, materially lagging ATS growth and reflecting an ongoing mix transition that may pressure near-term top-line growth in legacy offerings.
Read all updates
Q1-2026 Updates
Positive
Negative
Record start to fiscal year
Total revenue $1.296B, up 6.7% year-over-year; company reiterates full-year expectation of at least 7% growth (as-reported). Q2 revenue guidance $1.324B–$1.336B (~6% growth at midpoint).
Read all positive updates
Company Guidance
Genpact guided to at least 7% revenue growth for fiscal 2026 (as‑reported) with Advanced Technology Solutions now expected to grow at least 20% (Q1 ATS was $345M, +24% YoY and 27% of revenue); full‑year gross margin is expected to expand ~50 bps to 36.5% and adjusted operating income margin to increase ~25 bps to 17.7%, with adjusted diluted EPS forecast to grow over 10% (Q1 adjusted diluted EPS was $0.98, +16.7% YoY; Q1 total revenue $1.296B, +6.7%). For Q2 they expect revenue of $1.324–$1.336B (midpoint ≈6% YoY), ATS growth ≥20%, gross margin ~36.4%, adjusted operating income margin ~17.4%, and adjusted diluted EPS of $0.96–$0.97; management also cited record backlog, pipeline and inflows, six large deals in Q1, non‑FTE revenue at 48%, partner revenue up 35% to ~13% of total, $578M cash, and $102M returned to shareholders in Q1.Genpact Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
83
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.16B | 5.08B | 4.77B | 4.48B | 4.37B | 4.02B |
| Gross Profit | 1.88B | 1.81B | 1.69B | 1.57B | 1.54B | 1.43B |
| EBITDA | 874.27M | 874.70M | 852.58M | 772.52M | 652.86M | 709.01M |
| Net Income | 569.63M | 552.49M | 513.67M | 631.25M | 353.40M | 369.45M |
Balance Sheet | ||||||
| Total Assets | 5.62B | 5.84B | 4.99B | 4.81B | 4.59B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 928.08M | 1.20B | 671.61M | 583.67M | 646.76M | 899.46M |
| Total Debt | 1.76B | 1.76B | 1.45B | 1.50B | 1.70B | 2.00B |
| Total Liabilities | 3.14B | 3.29B | 2.60B | 2.56B | 2.76B | 3.08B |
| Stockholders Equity | 2.48B | 2.55B | 2.39B | 2.25B | 1.83B | 1.90B |
Cash Flow | ||||||
| Free Cash Flow | 666.35M | 734.65M | 530.19M | 432.04M | 389.28M | 637.03M |
| Operating Cash Flow | 748.88M | 812.86M | 615.42M | 490.81M | 443.67M | 694.28M |
| Investing Cash Flow | -527.72M | -495.50M | -105.96M | -78.94M | -36.59M | -122.75M |
| Financing Cash Flow | -185.60M | -106.81M | -424.85M | -483.00M | -571.40M | -332.88M |
Genpact Technical Analysis
Negative
34.18
Price Trends
35.15
Negative
38.62
Negative
40.73
Negative
Market Momentum
-1.19
Negative
42.80
Neutral
67.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For G, the sentiment is Negative. The current price of 34.18 is above the 20-day moving average (MA) of 32.44, below the 50-day MA of 35.15, and below the 200-day MA of 40.73, indicating a bearish trend. The MACD of -1.19 indicates Negative momentum. The RSI at 42.80 is Neutral, neither overbought nor oversold. The STOCH value of 67.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for G.
Genpact Risk Analysis
Genpact disclosed 43 risk factors in its most recent earnings report. Genpact reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Genpact Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $4.51B | 17.71 | 27.16% | ― | 13.35% | 18.39% | |
71 Outperform | $5.41B | 10.72 | 22.44% | 1.41% | 6.47% | 10.82% | |
63 Neutral | $5.36B | 22.07 | 10.67% | ― | 14.21% | -2.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | $2.77B | 15.13 | 21.67% | ― | 0.23% | -20.13% | |
48 Neutral | $1.55B | ― | 0.58% | ― | -1.76% | -96.67% |
* Technology Sector Average
G
Genpact
31.91
-10.89
-25.44%
EPAM
Epam Systems
102.69
-73.26
-41.64%
EXLS
Exlservice Holdings
29.51
-16.07
-35.26%
DXC
DXC Technology
9.50
-5.25
-35.59%
KD
Kyndryl Holdings Incorporation
12.29
-26.58
-68.38%
Genpact Corporate Events
Business Operations and StrategyShareholder Meetings
Genpact Shareholders Back Board, Pay and Auditor at AGM
Positive
Apr 29, 2026
On April 23, 2026, Genpact Limited held its 2026 annual general meeting of shareholders in New York, where investors voted on board composition, executive pay, and the company’s external auditor. Shareholders elected all nominated directors ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.